GLP-1s Are Easy To Get Now. That’s The Problem.

Written by

in

GLP-1 drugs are fueling a surge in direct-to-consumer medications. But convenience may be replacing coordination—and creating new risks for patients.

Continue Reading

News Source: www.forbes.com

Comments

Leave a Reply Cancel reply

More posts

Israeli military says Hezbollah launched missile at Israel, triggering sirens

April 9, 2026
Ecuador hikes tariffs to 100-percent in feud with neighbour Colombia | Government News

April 9, 2026
Police in Venezuela block protesters calling for higher wages, pensions | Protests News

April 9, 2026
US-Iran ceasefire: Uncertainty over what’s next | Conflict

April 9, 2026